Supernus Pharmaceuticals Goodwill

Supernus Pharmaceuticals (SUPN) currently reports a goodwill of $0 as of September 2026. That compares with $120M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Supernus Pharmaceuticals's goodwill history and peer comparisons.

Supernus Pharmaceuticals's goodwill decreased from $120M to $0 — a 100.0% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Supernus Pharmaceuticals reported $0 in goodwill as of September 2026. That compares with $120M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Supernus Pharmaceuticals, and consider following SUPN for alerts when major investors trade the stock.

Supernus Pharmaceuticals is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SUPN with unrelated industries.